Latest filing published 12 Jun 2025 for Atara Biotherapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Maria Grazia Roncarolo: trading record in brief
This profile gathers the share dealings of Maria Grazia Roncarolo in Atara Biotherapeutics, Inc., where the filings describe the role as board member. Over a trading history stretching from 8 June 2021 to 10 June 2025, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 12 June 2025 came the latest disclosure, a share grant in Atara Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Maria Grazia Roncarolo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,828 shares0Common StockSEC:0000905148-25-002139:0
- 150,000 shares0Common StockSEC:0000905148-24-001058:0
- 57,000 shares0Common StockSEC:0001140361-23-028154:0
- 20,500 shares0Common StockSEC:0001140361-22-024162:0
- 11,000 shares0Common StockSEC:0001140361-21-020439:0
5 of 5 declarations
